When clinical investigators and study coordinators start planning a new study design in the new normal, speed and efficiency are paramount.
Running a clinical study takes careful planning. Whether this is your 1st clinical study or your 21st, the last thing you probably want to do is waste resources on delays caused by easily-preventable hurdles in data collection.
Traditionally, major bottlenecks occur during study startup, eligibility screening, informed consent (including assent in pediatric studies), and patient travel to the clinical site(s). Researchers eager to get the ball rolling on their study can save time and logistical burden by stopping these bottlenecks before they begin.
To read more, please download this free white paper.